Lifecore Biomedical Q4 EPS $(0.06) Beats $(0.10) Estimate, Sales $36.444M Beat $35.363M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 36.84 percent. This is a 70 percent increase over losses of $(0.20) per share from
Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 36.84 percent. This is a 70 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $36.444 million which beat the analyst consensus estimate of $35.363 million by 3.06 percent. This is a 3.81 percent decrease over sales of $37.886 million the same period last year.